Observational analysis assesses viable cell counts and anti-inflammatory effects of lactic acid bacteria products in different storage positions, suggesting optimized strategies are needed.
This study examined changes in viable cell counts and functional efficacy (anti-inflammatory effects) of lactic acid bacteria (LAB) products (in pouch and stick forms) based on storage period and loading positions (outer-deck, on-deck, and under-deck) in a simulated marine shipping environment. Viable cell counts of pouch products, measured on days 1, 7, 14, and 21, showed a greater decrease under the outer-deck condition (13.5, 11.1, 7.5, and 8.0 log CFU/g) compared to the on-deck and under-deck conditions. Stick products also experienced significant reductions over time, with values of 12.0, 4.1, 3.2, and 2.1 log CFU/g under the outer-deck condition. The anti-inflammatory effect was evaluated through nitric oxide production, and the pouch product showed production of 34.4%, 57.7%, and 62.1% on days 1, 11, and 21, respectively, while the stick product showed production of 45.3%, 88.2%, and 90.5%. Cytokine production assays confirmed a decline in anti-inflammatory effects for products stored under outer-deck conditions. These results suggest that the viable cell counts and efficacy of LAB products are significantly impacted by storage position during marine shipping, particularly under outer-deck storage. Optimized storage and transportation strategies are necessary to maintain viability and functional efficacy, thereby enhancing product quality and consumer trust.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: